1. Home
  2. KYMR vs CPB Comparison

KYMR vs CPB Comparison

Compare KYMR & CPB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kymera Therapeutics Inc.

KYMR

Kymera Therapeutics Inc.

HOLD

Current Price

$80.14

Market Cap

7.1B

Sector

Health Care

ML Signal

HOLD

Logo Campbell Soup Company

CPB

Campbell Soup Company

HOLD

Current Price

$20.15

Market Cap

6.2B

ML Signal

HOLD

Company Overview

Basic Information
Metric
KYMR
CPB
Founded
2015
1869
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Packaged Foods
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
7.1B
6.2B
IPO Year
2020
1994

Fundamental Metrics

Financial Performance
Metric
KYMR
CPB
Price
$80.14
$20.15
Analyst Decision
Strong Buy
Hold
Analyst Count
26
18
Target Price
$107.72
$26.06
AVG Volume (30 Days)
451.5K
6.5M
Earning Date
04-30-2026
06-01-2026
Dividend Yield
N/A
7.63%
EPS Growth
N/A
6.35
EPS
N/A
1.13
Revenue
$39,211,000.00
$10,253,000,000.00
Revenue This Year
$10.61
N/A
Revenue Next Year
$8.17
$0.11
P/E Ratio
N/A
$18.21
Revenue Growth
N/A
6.40
52 Week Low
$28.33
$19.56
52 Week High
$103.00
$35.00

Technical Indicators

Market Signals
Indicator
KYMR
CPB
Relative Strength Index (RSI) 43.79 42.83
Support Level $77.71 $19.90
Resistance Level $89.80 $21.46
Average True Range (ATR) 3.13 0.60
MACD -0.47 0.03
Stochastic Oscillator 25.50 33.68

Price Performance

Historical Comparison
KYMR
CPB

About KYMR Kymera Therapeutics Inc.

Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of differentiated medicines that address health problems and meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, and IRAK4.

About CPB Campbell Soup Company

Over the past 150-plus years, Campbell's has evolved into a leading domestic packaged food manufacturer, with a portfolio that extends beyond its iconic red-and-white labeled canned soup. In fiscal 2025 (July year-end), snacks accounted for 43% of its revenue, followed by soup (27%), other simple meals (23%), and beverages (7%). Beyond its namesake, its brands include Pepperidge Farm, Goldfish, Snyder's of Hanover, Swanson, Pacific Foods, Prego, Pace, V8, and, most recently, Rao's (a deal that closed in 2024). Around 90% of its revenue results from the US and the remainder from Canada and Latin America.

Share on Social Networks: